Prudent Man Advisors LLC Acquires Shares of 1,608 Integer Holdings Co. (NYSE:ITGR)

Prudent Man Advisors LLC bought a new position in Integer Holdings Co. (NYSE:ITGR) in the third quarter, HoldingsChannel.com reports. The fund bought 1,608 shares of the medical equipment provider’s stock, valued at approximately $209,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Vanguard Group Inc. lifted its holdings in Integer by 0.6% during the 1st quarter. Vanguard Group Inc. now owns 3,826,088 shares of the medical equipment provider’s stock valued at $446,428,000 after purchasing an additional 23,382 shares during the last quarter. Earnest Partners LLC raised its stake in shares of Integer by 3.2% in the second quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock valued at $139,911,000 after acquiring an additional 37,340 shares during the last quarter. Congress Asset Management Co. boosted its holdings in shares of Integer by 3.9% in the 3rd quarter. Congress Asset Management Co. now owns 488,785 shares of the medical equipment provider’s stock worth $63,542,000 after acquiring an additional 18,303 shares in the last quarter. Driehaus Capital Management LLC grew its position in Integer by 62.5% during the 2nd quarter. Driehaus Capital Management LLC now owns 353,052 shares of the medical equipment provider’s stock worth $40,880,000 after acquiring an additional 135,750 shares during the last quarter. Finally, Tributary Capital Management LLC increased its holdings in Integer by 0.3% during the 2nd quarter. Tributary Capital Management LLC now owns 286,449 shares of the medical equipment provider’s stock valued at $33,168,000 after purchasing an additional 772 shares in the last quarter. Institutional investors own 99.29% of the company’s stock.

Integer Trading Up 1.0 %

ITGR opened at $134.55 on Tuesday. The firm has a 50 day simple moving average of $129.20 and a 200 day simple moving average of $122.75. Integer Holdings Co. has a fifty-two week low of $84.75 and a fifty-two week high of $140.91. The company has a market cap of $4.51 billion, a price-to-earnings ratio of 41.53, a price-to-earnings-growth ratio of 1.91 and a beta of 1.09. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09.

Integer (NYSE:ITGR) last issued its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, beating the consensus estimate of $1.36 by $0.07. Integer had a net margin of 6.70% and a return on equity of 11.63%. The company had revenue of $431.42 million during the quarter, compared to analysts’ expectations of $440.59 million. During the same quarter in the previous year, the company posted $1.27 EPS. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. On average, sell-side analysts anticipate that Integer Holdings Co. will post 5.34 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts have commented on the company. Bank of America boosted their price objective on Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a research note on Tuesday, October 1st. Truist Financial decreased their price objective on shares of Integer from $150.00 to $147.00 and set a “buy” rating on the stock in a report on Friday, October 25th. KeyCorp boosted their target price on shares of Integer from $139.00 to $144.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 15th. Benchmark raised their price target on shares of Integer from $130.00 to $140.00 and gave the company a “buy” rating in a report on Monday, October 21st. Finally, Citigroup boosted their price objective on shares of Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 1st. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, Integer currently has an average rating of “Moderate Buy” and a consensus price target of $139.75.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.